Article
Association Between N-acetyltransferase 2 Polymorphism and Bladder Cancer Risk: Results From Studies of the Past Decade and a Meta-Analysis.
Clinical genitourinary cancer - 1 Apr 2016
Wu Haoran, Wang Xugang, Zhang Liang, Mo Naixin, Lv Zhong
Abstract excerpt
Numerous studies have identified that the slow acetylation status of N-acetyltransferase 2 (NAT2) is associated with an elevated bladder cancer risk. However, the results remain inconclusive. The aim of our study was to evaluate the effect of NAT2 acetylation status in patients with bladder cancer. Electronic databases were searched to retrieve related studies published in the past decade. The pooled odds ratio...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
